Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Study of Unfavorable Treatment Outcome Between Mycobacterium Abscessus Infection in Patients With Chronic Lung Disease and Acquired Interferon-gamma Autoantibody Syndrome Within 1 Year of Appropriate Treatment

NCT05354583 is registered in ClinicalTrials.gov with King Chulalongkorn Memorial Hospital as lead sponsor.

NCT NCT05354583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05354583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Study of Unfavorable Treatment Outcome Between Mycobacterium Abscessus Infection in Patients With Chronic Lung Disease and Acquired Interferon-gamma Autoantibody Syndrome Within 1 Year of Appropriate Treatment
Lead sponsor
King Chulalongkorn Memorial Hospital
Phase
Observational
Overall status
Completed
Start date
June 15, 2022
Completion date
September 30, 2023
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult-onset immunodeficiency with acquired anti-interferon-gamma autoantibodies, mycobacterium abscessus infection, nontuberculous mycobacterial pulmonary infection